3,851
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening

Pages 891-905 | Received 06 Apr 2017, Accepted 17 May 2017, Published online: 02 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emma Innes, Humphrey H. P. Yiu, Polly McLean, William Brown & Matthew Boyles. (2021) Simulated biological fluids – a systematic review of their biological relevance and use in relation to inhalation toxicology of particles and fibres. Critical Reviews in Toxicology 51:3, pages 217-248.
Read now
Ziyu Zhao, Zhengwei Huang, Xuejuan Zhang, Ying Huang, Yingtong Cui, Cheng Ma, Guanlin Wang, Tim Freeman, Xiang-yun Lu, Xin Pan & Chuanbin Wu. (2018) Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement. Expert Opinion on Drug Delivery 15:5, pages 443-457.
Read now

Articles from other publishers (22)

Prakash Khadka, Ian G. Tucker & Shyamal C. Das. (2022) In vitro Dissolution Testing of Rifampicin Powder Formulations For Prediction of Plasma Concentration–Time Profiles After Inhaled Delivery. Pharmaceutical Research 40:5, pages 1153-1163.
Crossref
Claudia Meindl, Markus Absenger-Novak, Ramona Jeitler, Eva Roblegg & Eleonore Fröhlich. (2023) Assessment of Carbon Nanotubes on Barrier Function, Ciliary Beating Frequency and Cytokine Release in In Vitro Models of the Respiratory Tract. Nanomaterials 13:4, pages 682.
Crossref
Jisheng Zhang, Keheng Wu, Bo Liu, Shuguang Hou, Xue Li, Xiang Ye, Jack Liu & Qing He. (2023) Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling. Frontiers in Medicine 10.
Crossref
Érika Yoko Suzuki, Alice Simon, Thaisa Francielle Souza Domingos, Bárbara de Azevedo Abrahim Vieira, Alessandra Mendonça Teles de Souza, Carlos Rangel Rodrigues, Valeria Pereira de Sousa, Flávia Almada do Carmo & Lucio Mendes Cabral. (2023) Alternative Methods for Pulmonary-Administered Drugs Metabolism: A Breath of Change. Mini-Reviews in Medicinal Chemistry 23:2, pages 170-186.
Crossref
Foziyah Zakir, Mamta Bishnoi & Geeta Aggarwal. 2023. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases 183 198 .
Basanth Babu Eedara, Rakesh Bastola & Shyamal C. Das. (2022) Dissolution and Absorption of Inhaled Drug Particles in the Lungs. Pharmaceutics 14:12, pages 2667.
Crossref
F. Bahman & S. Taurin. 2022. Nanotechnology for Diabetes Management. Nanotechnology for Diabetes Management 165 187 .
Siyu He, Li Wu, Hongyu Sun, Di Wu, Caifen Wang, Xiaohong Ren, Qun Shao, Peter York, Jiabing Tong, Jie Zhu, Zegeng Li & Jiwen Zhang. (2022) Antioxidant Biodegradable Covalent Cyclodextrin Frameworks as Particulate Carriers for Inhalation Therapy against Acute Lung Injury. ACS Applied Materials & Interfaces 14:34, pages 38421-38435.
Crossref
Sara A. Valente, Lisete M. Silva, Guido R. Lopes, Bruno Sarmento, Manuel A. Coimbra & Cláudia P. Passos. (2022) Polysaccharide-based formulations as potential carriers for pulmonary delivery – A review of their properties and fates. Carbohydrate Polymers 277, pages 118784.
Crossref
Eleonore Fröhlich. (2021) Replacement Strategies for Animal Studies in Inhalation Testing. Sci 3:4, pages 45.
Crossref
Eleonore Fröhlich & Sharareh Salar-Behzadi. (2021) Oral inhalation for delivery of proteins and peptides to the lungs. European Journal of Pharmaceutics and Biopharmaceutics 163, pages 198-211.
Crossref
Prakash Khadka, Shubhra Sinha, Ian G. Tucker, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2021) Studies on the safety and the tissue distribution of inhaled high-dose amorphous and crystalline rifampicin in a rat model. International Journal of Pharmaceutics 597, pages 120345.
Crossref
Vania Hinkovska-Galcheva, Taylour Treadwell, Jonathan M. Shillingford, Angela Lee, Akira Abe, John J.G. Tesmer & James A. Shayman. (2021) Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis. Journal of Lipid Research 62, pages 100089.
Crossref
Marja Talikka, Vincenzo Belcastro, Stéphanie Boué, Diego Marescotti, Julia Hoeng & Manuel C. Peitsch. 2021. Systems Medicine. Systems Medicine 330 341 .
Yamini Dhayanandamoorthy, M. Gover Antoniraj, Chaya A. Babu Kandregula & Ruckmani Kandasamy. (2020) Aerosolized hyaluronic acid decorated, ferulic acid loaded chitosan nanoparticle: A promising asthma control strategy. International Journal of Pharmaceutics 591, pages 119958.
Crossref
Bryan Newman & Kimberly Witzmann. (2020) Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products. Pharmaceutical Medicine 34:2, pages 93-102.
Crossref
S. Zellnitz, L. Zellnitz, M.T. Müller, C. Meindl, H. Schröttner & E. Fröhlich. (2019) Impact of drug particle shape on permeability and cellular uptake in the lung. European Journal of Pharmaceutical Sciences 139, pages 105065.
Crossref
Eleonore Fröhlich. (2019) Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations. Pharmaceutics 11:7, pages 316.
Crossref
Basanth Babu Eedara, Ian G. Tucker & Shyamal C. Das. (2019) In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatus. International Journal of Pharmaceutics 559, pages 235-244.
Crossref
Sarah Zellnitz, Eva Roblegg, Joana Pinto & Eleonore Fröhlich. (2019) Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View. Current Drug Delivery 16:3, pages 180-194.
Crossref
Snezana Radivojev, Sarah Zellnitz, Amrit Paudel & Eleonore Fröhlich. (2019) Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs. International Journal of Pharmaceutics 556, pages 45-56.
Crossref
Aamer Saeed, Alejandra Bosch, Marisa Bettiol, Diana Nossa González, Mauricio Erben & Yanina Lamberti. (2018) Novel Guanidine Compound against Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species. Molecules 23:5, pages 1158.
Crossref